These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36656142)

  • 1. YAP/TAZ axis was involved in the effects of metformin on breast cancer.
    Xu Y; Cai H; Xiong Y; Tang L; Li L; Zhang L; Shen Y; Yang Y; Lin L; Huang J
    J Chemother; 2023 Nov; 35(7):627-637. PubMed ID: 36656142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells.
    Fu J; Liu W; Liu S; Zhao R; Hayashi T; Zhao H; Xiang Y; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Cell Signal; 2024 Jul; 119():111186. PubMed ID: 38643945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
    Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
    Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
    [No Abstract]   [Full Text] [Related]  

  • 4. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.
    Luo J; Zou H; Guo Y; Tong T; Chen Y; Xiao Y; Pan Y; Li P
    Br J Cancer; 2023 May; 128(9):1611-1624. PubMed ID: 36759723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges.
    Kumar A; BharathwajChetty B; Manickasamy MK; Unnikrishnan J; Alqahtani MS; Abbas M; Almubarak HA; Sethi G; Kunnumakkara AB
    Pharmacol Res; 2024 May; 203():107167. PubMed ID: 38599470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of YAP/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells.
    Kim YJ; Jang SK; Hong SE; Park CS; Seong MK; Kim HA; Park KS; Kim CH; Park IC; Jin HO
    Biochem Biophys Res Commun; 2022 Apr; 601():73-78. PubMed ID: 35231654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
    Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metformin inhibits proliferation and promotes apoptosis of HER-2 positive breast cancer cells possibly through the Hippo-YAP pathway].
    Xu Y; Xu T; Xiong Y; Huang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):740-746. PubMed ID: 35673919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
    Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
    Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.
    Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
    Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
    Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer.
    Zhao W; Wang M; Cai M; Zhang C; Qiu Y; Wang X; Zhang T; Zhou H; Wang J; Zhao W; Shao R
    Biomed Pharmacother; 2021 Jan; 133():110956. PubMed ID: 33189066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells.
    Liu Q; Stel WV; Noord VEV; Leegwater H; Coban B; Elbertse K; Pruijs JTM; Béquignon OJM; Westen GV; Dévédec SEL; Danen EHJ
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
    Gershoni A; Hassin O; Nataraj NB; Baruch S; Avioz-Seligman A; Pirona AC; Fellus-Alyagor L; Meir Salame T; Mukherjee S; Mallel G; Yarden Y; Aylon Y; Oren M
    Mol Oncol; 2023 Dec; 17(12):2675-2693. PubMed ID: 37716913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ.
    Xekouki P; Lodge EJ; Matschke J; Santambrogio A; Apps JR; Sharif A; Jacques TS; Aylwin S; Prevot V; Li R; Flitsch J; Bornstein SR; Theodoropoulou M; Andoniadou CL
    Endocr Relat Cancer; 2019 Jan; 26(1):215-225. PubMed ID: 30139767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of stem cell renewal and fate by YAP and TAZ.
    Driskill JH; Pan D
    Nat Rev Mol Cell Biol; 2023 Dec; 24(12):895-911. PubMed ID: 37626124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation.
    Luo J; Li P
    Stem Cell Res Ther; 2022 Jan; 13(1):10. PubMed ID: 35012640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers.
    Howard A; Bojko J; Flynn B; Bowen S; Jungwirth U; Walko G
    Exp Dermatol; 2022 Oct; 31(10):1477-1499. PubMed ID: 35913427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Vici P; Ercolani C; Di Benedetto A; Pizzuti L; Di Lauro L; Sperati F; Terrenato I; Gamucci T; Natoli C; Di Filippo F; Botti C; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
    J Exp Clin Cancer Res; 2016 Apr; 35():62. PubMed ID: 27039292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.